Abstract
Bid, a pro-apoptotic member of the Bcl-2 family, was initially discovered through binding to both pro-apoptotic Bax and anti-apoptotic Bcl-2. During apoptosis, Bid can be cleaved not only by caspase-8 during death receptor apoptotic signaling, but also by other caspases, granzyme B, calpains and cathepsins. Protease-cleaved Bid migrates to mitochondria where it induces permeabilization of the outer mitochondrial membrane that is dependent on the pro-apoptotic proteins Bax and/or Bak, and thus Bid acts as a sentinel for protease-mediated death signals. Although sequence analysis suggests that Bid belongs to the BH3-only subgroup of the Bcl-2 family, structural and phylogenetic analysis suggests that Bid may be more related to multi-BH region proteins such as pro-apoptotic Bax. Analysis of membrane binding by protease-cleaved Bid reveals mechanistic similarities with the membrane binding of Bax. For both proteins, membrane binding is characterized by relief of N-terminal inhibition of sequences promoting migration to membranes, insertion into the bilayer of the central hydrophobic hairpin helices and exposure of the BH3 region. These findings implicate Bid as a BH3-only protein that is both structurally and functionally related to multi-BH region Bcl-2 family proteins such as Bax.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Annis MG, Soucie EL, Dlugosz PJ, Cruz-Aguado JA, Penn LZ, Leber B et al. (2005). Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO J 24: 2096–2103.
Aouacheria A, Brunet F, Gouy M . (2005). Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators. Mol Biol Evol 22: 2395–2416.
Arokium H, Camougrand N, Vallette FM, Manon S . (2004). Studies of the interaction of substituted mutants of BAX with yeast mitochondria reveal that the C-terminal hydrophobic alpha-helix is a second ART sequence and plays a role in the interaction with anti-apoptotic BCL-xL. J Biol Chem 279: 52566–52573.
Arokium H, Ouerfelli H, Velours G, Camougrand N, Vallette FM, Manon S . (2007). Substitutions of potentially phosphorylatable serine residues of Bax reveal how they may regulate its interaction with mitochondria. J Biol Chem 282: 35104–35112.
Billen LP, Kokoski CL, Lovell JF, Leber B, Andrews DW . (2008). Bcl-XL inhibits membrane permeabilization by competing with Bax. PLoS Biol 6: e147.
Blomgran R, Zheng L, Stendahl O . (2007). Cathepsin-cleaved Bid promotes apoptosis in human neutrophils via oxidative stress-induced lysosomal membrane permeabilization. J Leukoc Biol 81: 1213–1223.
Cartron PF, Arokium H, Oliver L, Meflah K, Manon S, Vallette FM . (2005). Distinct domains control the addressing and the insertion of Bax into mitochondria. J Biol Chem 280: 10587–10598.
Cartron PF, Gallenne T, Bougras G, Gautier F, Manero F, Vusio P et al. (2004). The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA. Mol Cell 16: 807–818.
Cartron PF, Moreau C, Oliver L, Mayat E, Meflah K, Vallette FM . (2002a). Involvement of the N-terminus of Bax in its intracellular localization and function. FEBS Lett 512: 95–100.
Cartron PF, Oliver L, Martin S, Moreau C, LeCabellec MT, Jezequel P et al. (2002b). The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients. Hum Mol Genet 11: 675–687.
Cartron PF, Priault M, Oliver L, Meflah K, Manon S, Vallette FM . (2003). The N-terminal end of Bax contains a mitochondrial-targeting signal. J Biol Chem 278: 11633–11641.
Certo M, Del Gaizo Moore V, Nishino M, Wei G, Korsmeyer S, Armstrong SA et al. (2006). Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 9: 351–365.
Chen M, He H, Zhan S, Krajewski S, Reed JC, Gottlieb RA . (2001). Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J Biol Chem 276: 30724–30728.
Chiang CW, Kanies C, Kim KW, Fang WB, Parkhurst C, Xie M et al. (2003). Protein phosphatase 2A dephosphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis. Mol Cell Biol 23: 6350–6362.
Chou JJ, Li H, Salvesen GS, Yuan J, Wagner G . (1999). Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96: 615–624.
Cirman T, Oresic K, Mazovec GD, Turk V, Reed JC, Myers RM et al. (2004). Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 279: 3578–3587.
Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB et al. (2000). 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 6: 41–51.
Day CL, Chen L, Richardson SJ, Harrison PJ, Huang DC, Hinds MG . (2005). Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J Biol Chem 280: 4738–4744.
Degli Esposti M, Ferry G, Masdehors P, Boutin JA, Hickman JA, Dive C . (2003). Post-translational modification of Bid has differential effects on its susceptibility to cleavage by caspase 8 or caspase 3. J Biol Chem 278: 15749–15757.
Deng Y, Ren X, Yang L, Lin Y, Wu X . (2003). A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 115: 61–70.
Denisov AY, Madiraju MS, Chen G, Khadir A, Beauparlant P, Attardo G et al. (2003). Solution structure of human BCL-w: modulation of ligand binding by the C-terminal helix. J Biol Chem 278: 21124–21128.
Desagher S, Osen-Sand A, Montessuit S, Magnenat E, Vilbois F, Hochmann A et al. (2001). Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol Cell 8: 601–611.
Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S et al. (1999). Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 144: 891–901.
Donovan N, Becker EB, Konishi Y, Bonni A . (2002). JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery. J Biol Chem 277: 40944–40949.
Eskes R, Desagher S, Antonsson B, Martinou JC . (2000). Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 20: 929–935.
Garcia-Saez AJ, Coraiola M, Dalla Serra M, Mingarro I, Menestrina G, Salgado J . (2005). Peptides derived from apoptotic Bax and Bid reproduce the poration activity of the parent full-length proteins. Biophys J 88: 3976–3990.
Garcia-Saez AJ, Mingarro I, Perez-Paya E, Salgado J . (2004). Membrane-insertion fragments of Bcl-xL, Bax, and Bid. Biochemistry 43: 10930–10943.
Gardai SJ, Hildeman DA, Frankel SK, Whitlock BB, Frasch SC, Borregaard N et al. (2004). Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 279: 21085–21095.
Gilmore AP, Metcalfe AD, Romer LH, Streuli CH . (2000). Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J Cell Biol 149: 431–446.
Gong XM, Choi J, Franzin CM, Zhai D, Reed JC, Marassi FM . (2004). Conformation of membrane-associated proapoptotic tBid. J Biol Chem 279: 28954–28960.
Goping IS, Gross A, Lavoie JN, Nguyen M, Jemmerson R, Roth K et al. (1998). Regulated targeting of BAX to mitochondria. J Cell Biol 143: 207–215.
Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C et al. (1999). Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274: 1156–1163.
Heibein JA, Goping IS, Barry M, Pinkoski MJ, Shore GC, Green DR et al. (2000). Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax. J Exp Med 192: 1391–1402.
Heimlich G, McKinnon AD, Bernardo K, Brdiczka D, Reed JC, Kain R et al. (2004). Bax-induced cytochrome c release from mitochondria depends on alpha-helices-5 and -6. Biochem J 378: 247–255.
Hinds MG, Lackmann M, Skea GL, Harrison PJ, Huang DC, Day CL . (2003). The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity. EMBO J 22: 1497–1507.
Hinds MG, Smits C, Fredericks-Short R, Risk JM, Bailey M, Huang DC et al. (2007). Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets. Cell Death Differ 14: 128–136.
Hsu YT, Youle RJ . (1997). Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 272: 13829–13834.
Hsu YT, Youle RJ . (1998). Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J Biol Chem 273: 10777–10783.
Hu X, Han Z, Wyche JH, Hendrickson EA . (2003). Helix 6 of tBid is necessary but not sufficient for mitochondrial binding activity. Apoptosis 8: 277–289.
Jeong SY, Gaume B, Lee YJ, Hsu YT, Ryu SW, Yoon SH et al. (2004). Bcl-x(L) sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers. EMBO J 23: 2146–2155.
Kamer I, Sarig R, Zaltsman Y, Niv H, Oberkovitz G, Regev L et al. (2005). Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 122: 593–603.
Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ et al. (2006). Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8: 1348–1358.
Kim TH, Zhao Y, Ding WX, Shin JN, He X, Seo YW et al. (2004). Bid-cardiolipin interaction at mitochondrial contact site contributes to mitochondrial cristae reorganization and cytochrome C release. Mol Biol Cell 15: 3061–3072.
Klumpp S, Selke D, Krieglstein J . (2003). Protein phosphatase type 2C dephosphorylates BAD. Neurochem Int 42: 555–560.
Konishi Y, Lehtinen M, Donovan N, Bonni A . (2002). Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol Cell 9: 1005–1016.
Kutuk O, Letai A . (2008). Regulation of Bcl-2 family proteins by posttranslational modifications. Curr Mol Med 8: 102–118.
Kvansakul M, Yang H, Fairlie WD, Czabotar PE, Fischer SF, Perugini MA et al. (2008). Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ 15: 1564–1571.
Lei K, Davis RJ . (2003). JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA 100: 2432–2437.
Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ . (2002). Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2: 183–192.
Li H, Zhu H, Xu CJ, Yuan J . (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491–501.
Linseman DA, Butts BD, Precht TA, Phelps RA, Le SS, Laessig TA et al. (2004). Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci 24: 9993–10002.
Liu X, Dai S, Zhu Y, Marrack P, Kappler JW . (2003). The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. Immunity 19: 341–352.
Lovell JF, Billen LP, Bindner S, Shamas-Din A, Fradin C, Leber B et al. (2008). Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 135: 1074–1084.
Luo X, Budihardjo I, Zou H, Slaughter C, Wang X . (1998). Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481–490.
Lutter M, Fang M, Luo X, Nishijima M, Xie X, Wang X . (2000). Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat Cell Biol 2: 754–761.
Mandic A, Viktorsson K, Strandberg L, Heiden T, Hansson J, Linder S et al. (2002). Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis. Mol Cell Biol 22: 3003–3013.
McDonnell JM, Fushman D, Milliman CL, Korsmeyer SJ, Cowburn D . (1999). Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96: 625–634.
Moldoveanu T, Liu Q, Tocilj A, Watson M, Shore G, Gehring K . (2006). The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Mol Cell 24: 677–688.
Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS et al. (1996). X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381: 335–341.
Nechushtan A, Smith CL, Hsu YT, Youle RJ . (1999). Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J 18: 2330–2341.
Nouraini S, Six E, Matsuyama S, Krajewski S, Reed JC . (2000). The putative pore-forming domain of Bax regulates mitochondrial localization and interaction with Bcl-X(L). Mol Cell Biol 20: 1604–1615.
O’Connor L, Strasser A, O’Reilly LA, Hausmann G, Adams JM, Cory S et al. (1998). Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 17: 384–395.
Oh KJ, Barbuto S, Meyer N, Kim RS, Collier RJ, Korsmeyer SJ . (2005). Conformational changes in BID, a pro-apoptotic BCL-2 family member, upon membrane binding. A site-directed spin labeling study. J Biol Chem 280: 753–767.
Parker MW, Pattus F . (1993). Rendering a membrane protein soluble in water: a common packing motif in bacterial protein toxins. Trends Biochem Sci 18: 391–395.
Petros AM, Medek A, Nettesheim DG, Kim DH, Yoon HS, Swift K et al. (2001). Solution structure of the antiapoptotic protein bcl-2. Proc Natl Acad Sci USA 98: 3012–3017.
Petros AM, Nettesheim DG, Wang Y, Olejniczak ET, Meadows RP, Mack J et al. (2000). Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci 9: 2528–2534.
Peyerl FW, Dai S, Murphy GA, Crawford F, White J, Marrack P et al. (2007). Elucidation of some Bax conformational changes through crystallization of an antibody-peptide complex. Cell Death Differ 14: 447–452.
Priault M, Cartron PF, Camougrand N, Antonsson B, Vallette FM, Manon S . (2003). Investigation of the role of the C-terminus of Bax and of tc-Bid on Bax interaction with yeast mitochondria. Cell Death Differ 10: 1068–1077.
Puthalakath H, Huang DC, O’Reilly LA, King SM, Strasser A . (1999). The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 3: 287–296.
Qi XJ, Wildey GM, Howe PH . (2006). Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function. J Biol Chem 281: 813–823.
Reiners Jr JJ, Caruso JA, Mathieu P, Chelladurai B, Yin XM, Kessel D . (2002). Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ 9: 934–944.
Ruffolo SC, Shore GC . (2003). BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization. J Biol Chem 278: 25039–25045.
Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M et al. (1997). Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275: 983–986.
Schinzel A, Kaufmann T, Schuler M, Martinalbo J, Grubb D, Borner C . (2004). Conformational control of Bax localization and apoptotic activity by Pro168. J Cell Biol 164: 1021–1032.
Slee EA, Keogh SA, Martin SJ . (2000). Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release. Cell Death Differ 7: 556–565.
Smits C, Czabotar PE, Hinds MG, Day CL . (2008). Structural plasticity underpins promiscuous binding of the prosurvival protein A1. Structure 16: 818–829.
Stoka V, Turk B, Schendel SL, Kim TH, Cirman T, Snipas SJ et al. (2001). Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem 276: 3149–3157.
Sutton VR, Davis JE, Cancilla M, Johnstone RW, Ruefli AA, Sedelies K et al. (2000). Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation. J Exp Med 192: 1403–1414.
Sutton VR, Wowk ME, Cancilla M, Trapani JA . (2003). Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors. Immunity 18: 319–329.
Suzuki M, Youle RJ, Tjandra N . (2000). Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103: 645–654.
Tan C, Dlugosz PJ, Peng J, Zhang Z, Lapolla SM, Plafker SM et al. (2006). Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2. J Biol Chem 281: 14764–14775.
Tan KO, Tan KM, Yu VC . (1999). A novel BH3-like domain in BID is required for intramolecular interaction and autoinhibition of pro-apoptotic activity. J Biol Chem 274: 23687–23690.
Tan Y, Demeter MR, Ruan H, Comb MJ . (2000). BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. J Biol Chem 275: 25865–25869.
Toyota H, Yanase N, Yoshimoto T, Moriyama M, Sudo T, Mizuguchi J . (2003). Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax. Cancer Lett 189: 221–230.
Uren RT, Dewson G, Chen L, Coyne SC, Huang DC, Adams JM et al. (2007). Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak. J Cell Biol 177: 277–287.
Valentijn AJ, Metcalfe AD, Kott J, Streuli CH, Gilmore AP . (2003). Spatial and temporal changes in Bax subcellular localization during anoikis. J Cell Biol 162: 599–612.
Walensky LD, Pitter K, Morash J, Oh KJ, Barbuto S, Fisher J et al. (2006). A stapled BID BH3 helix directly binds and activates BAX. Mol Cell 24: 199–210.
Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F et al. (1999). Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284: 339–343.
Wang K, Yin XM, Chao DT, Milliman CL, Korsmeyer SJ . (1996). BID: a novel BH3 domain-only death agonist. Genes Dev 10: 2859–2869.
Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M et al. (2000). tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 14: 2060–2071.
Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI et al. (2005). Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19: 1294–1305.
Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ . (1997). Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139: 1281–1292.
Xin M, Deng X . (2005). Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem 280: 10781–10789.
Xin M, Gao F, May WS, Flagg T, Deng X . (2007). Protein kinase Czeta abrogates the proapoptotic function of Bax through phosphorylation. J Biol Chem 282: 21268–21277.
Yamaguchi H, Wang HG . (2002). Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL. J Biol Chem 277: 41604–41612.
Yethon JA, Epand RF, Leber B, Epand RM, Andrews DW . (2003). Interaction with a membrane surface triggers a reversible conformational change in Bax normally associated with induction of apoptosis. J Biol Chem 278: 48935–48941.
Youle RJ, Strasser A . (2008). The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47–59.
Zha J, Harada H, Osipov K, Jockel J, Waksman G, Korsmeyer SJ . (1997). BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity. J Biol Chem 272: 24101–24104.
Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ . (1996). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87: 619–628.
Zha J, Weiler S, Oh KJ, Wei MC, Korsmeyer SJ . (2000). Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 290: 1761–1765.
Zhou XM, Liu Y, Payne G, Lutz RJ, Chittenden T . (2000). Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. J Biol Chem 275: 25046–25051.
Zinkel SS, Hurov KE, Ong C, Abtahi FM, Gross A, Korsmeyer SJ . (2005). A role for proapoptotic BID in the DNA-damage response. Cell 122: 579–591.
Acknowledgements
The work in the author's laboratory was supported by grant FRN12517 from the Canadian Institute of Health Research (CIHR), a Tier I Canada Research Chair in Membrane Biogenesis to DWA and a CIHR Canada Graduate Scholarship to LPB.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Billen, L., Shamas-Din, A. & Andrews, D. Bid: a Bax-like BH3 protein. Oncogene 27 (Suppl 1), S93–S104 (2008). https://doi.org/10.1038/onc.2009.47
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2009.47
Keywords
This article is cited by
-
Crassostrea gigas peptide PEP-1 prevents tert-butyl hydroperoxide (t-BHP) induced oxidative stress in HepG2 cells
Food Science and Biotechnology (2024)
-
Regulation of anoikis by extrinsic death receptor pathways
Cell Communication and Signaling (2023)
-
Bifidobacterium animalis sup F1-7 Acts as an Effective Activator to Regulate Immune Response Via Casepase-3 and Bak of FAS/CD95 Pathway
Probiotics and Antimicrobial Proteins (2023)
-
Visfatin induces ovarian cancer resistance to anoikis by regulating mitochondrial activity
Endocrine (2023)
-
Natural killer cell-related gene signature predicts malignancy of glioma and the survival of patients
BMC Cancer (2022)